JP2017514818A5 - - Google Patents

Download PDF

Info

Publication number
JP2017514818A5
JP2017514818A5 JP2016564569A JP2016564569A JP2017514818A5 JP 2017514818 A5 JP2017514818 A5 JP 2017514818A5 JP 2016564569 A JP2016564569 A JP 2016564569A JP 2016564569 A JP2016564569 A JP 2016564569A JP 2017514818 A5 JP2017514818 A5 JP 2017514818A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
membered heteroaryl
compound
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016564569A
Other languages
English (en)
Japanese (ja)
Other versions
JP6574203B2 (ja
JP2017514818A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2015/052833 external-priority patent/WO2015166373A1/en
Publication of JP2017514818A publication Critical patent/JP2017514818A/ja
Publication of JP2017514818A5 publication Critical patent/JP2017514818A5/ja
Application granted granted Critical
Publication of JP6574203B2 publication Critical patent/JP6574203B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016564569A 2014-04-30 2015-04-17 シクロアルキル結合ジヘテロ環誘導体 Expired - Fee Related JP6574203B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461986876P 2014-04-30 2014-04-30
US61/986,876 2014-04-30
PCT/IB2015/052833 WO2015166373A1 (en) 2014-04-30 2015-04-17 Cycloalkyl-linked diheterocycle derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019149123A Division JP2019214597A (ja) 2014-04-30 2019-08-15 シクロアルキル結合ジヘテロ環誘導体

Publications (3)

Publication Number Publication Date
JP2017514818A JP2017514818A (ja) 2017-06-08
JP2017514818A5 true JP2017514818A5 (cg-RX-API-DMAC10.html) 2018-06-14
JP6574203B2 JP6574203B2 (ja) 2019-09-11

Family

ID=53276932

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016564569A Expired - Fee Related JP6574203B2 (ja) 2014-04-30 2015-04-17 シクロアルキル結合ジヘテロ環誘導体
JP2019149123A Ceased JP2019214597A (ja) 2014-04-30 2019-08-15 シクロアルキル結合ジヘテロ環誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019149123A Ceased JP2019214597A (ja) 2014-04-30 2019-08-15 シクロアルキル結合ジヘテロ環誘導体

Country Status (40)

Country Link
US (4) US20170050958A1 (cg-RX-API-DMAC10.html)
EP (2) EP3556757A1 (cg-RX-API-DMAC10.html)
JP (2) JP6574203B2 (cg-RX-API-DMAC10.html)
KR (1) KR20160149256A (cg-RX-API-DMAC10.html)
CN (1) CN106232598B (cg-RX-API-DMAC10.html)
AP (1) AP2016009530A0 (cg-RX-API-DMAC10.html)
AU (1) AU2015254943B2 (cg-RX-API-DMAC10.html)
BR (1) BR112016024513A2 (cg-RX-API-DMAC10.html)
CA (1) CA2947130C (cg-RX-API-DMAC10.html)
CL (1) CL2016002532A1 (cg-RX-API-DMAC10.html)
CR (1) CR20160497A (cg-RX-API-DMAC10.html)
CU (1) CU24420B1 (cg-RX-API-DMAC10.html)
CY (1) CY1122439T1 (cg-RX-API-DMAC10.html)
DK (1) DK3137460T3 (cg-RX-API-DMAC10.html)
DO (1) DOP2016000293A (cg-RX-API-DMAC10.html)
EA (1) EA033919B1 (cg-RX-API-DMAC10.html)
EC (1) ECSP16083017A (cg-RX-API-DMAC10.html)
ES (1) ES2759434T3 (cg-RX-API-DMAC10.html)
GE (2) GEP20186879B (cg-RX-API-DMAC10.html)
GT (1) GT201600232A (cg-RX-API-DMAC10.html)
HR (1) HRP20192056T1 (cg-RX-API-DMAC10.html)
HU (1) HUE046518T2 (cg-RX-API-DMAC10.html)
IL (1) IL248629B (cg-RX-API-DMAC10.html)
LT (1) LT3137460T (cg-RX-API-DMAC10.html)
MA (2) MA39926B1 (cg-RX-API-DMAC10.html)
MD (1) MD20160111A2 (cg-RX-API-DMAC10.html)
MX (1) MX2016014143A (cg-RX-API-DMAC10.html)
NI (1) NI201600163A (cg-RX-API-DMAC10.html)
NZ (1) NZ725496A (cg-RX-API-DMAC10.html)
PE (1) PE20161436A1 (cg-RX-API-DMAC10.html)
PH (1) PH12016501997B1 (cg-RX-API-DMAC10.html)
PL (1) PL3137460T3 (cg-RX-API-DMAC10.html)
PT (1) PT3137460T (cg-RX-API-DMAC10.html)
RS (1) RS59617B1 (cg-RX-API-DMAC10.html)
SG (1) SG11201608634RA (cg-RX-API-DMAC10.html)
SI (1) SI3137460T1 (cg-RX-API-DMAC10.html)
SV (1) SV2016005310A (cg-RX-API-DMAC10.html)
TN (1) TN2016000459A1 (cg-RX-API-DMAC10.html)
UA (1) UA117861C2 (cg-RX-API-DMAC10.html)
WO (1) WO2015166373A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160100407A (ko) * 2014-01-06 2016-08-23 리젠 파마슈티컬스 소시에떼 아노님 신규한 글루타미나제의 저해제
HRP20192056T1 (hr) * 2014-04-30 2020-02-21 Pfizer Inc. Derivati diheterocikla vezani na cikloalkil
CN107474024B (zh) * 2016-06-08 2022-12-13 北京赛林泰医药技术有限公司 一种谷氨酰酶抑制剂及其组合物和用途
CN110746416A (zh) * 2019-09-05 2020-02-04 中国药科大学 含有三氮唑结构的谷氨酰胺酶gls1抑制剂或其可药用的盐、其制备方法及用途
CN116023375A (zh) * 2021-10-25 2023-04-28 成都苑东生物制药股份有限公司 一种杂环类衍生物、其制备方法及用途

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2037257A1 (en) 1970-07-28 1972-02-03 Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt Poly-(5-amino-1,3,4-thiadiazol-2-yl) derivs prepn - intermediates for drug and polymer prodn
GB8607683D0 (en) 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
GB8827305D0 (en) 1988-11-23 1988-12-29 British Bio Technology Compounds
DE69222637T2 (de) 1991-05-10 1998-02-26 Rhone Poulenc Rorer Int Bis mono- und bicyclische aryl- und heteroarylderivate mit inhibierender wirkung auf die egf und/oder pdgf-rezeptor tyrosinkinase
NZ243082A (en) 1991-06-28 1995-02-24 Ici Plc 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
FI941572L (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
AU661533B2 (en) 1992-01-20 1995-07-27 Astrazeneca Ab Quinazoline derivatives
CA2372813A1 (en) 1992-02-06 1993-08-19 L.L. Houston Biosynthetic binding protein for cancer marker
US6177401B1 (en) 1992-11-13 2001-01-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
GB9323290D0 (en) 1992-12-10 1994-01-05 Zeneca Ltd Quinazoline derivatives
US5455258A (en) 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
GB9314884D0 (en) 1993-07-19 1993-09-01 Zeneca Ltd Tricyclic derivatives
GB9314893D0 (en) 1993-07-19 1993-09-01 Zeneca Ltd Quinazoline derivatives
IL112248A0 (en) 1994-01-25 1995-03-30 Warner Lambert Co Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
GB9510757D0 (en) 1994-09-19 1995-07-19 Wellcome Found Therapeuticaly active compounds
GB9424233D0 (en) 1994-11-30 1995-01-18 Zeneca Ltd Quinazoline derivatives
US5863949A (en) 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
US5702637A (en) 1995-04-19 1997-12-30 Minnesota Mining And Manufacturing Company Liquid crystal compounds having a chiral fluorinated terminal portion
CA2218503C (en) 1995-04-20 2001-07-24 Pfizer Inc. Arylsulfonyl hydroxamic acid derivatives
US5880141A (en) 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
JPH09104838A (ja) 1995-10-09 1997-04-22 Mitsui Toatsu Chem Inc 水性塗料用樹脂組成物
GB9520822D0 (en) 1995-10-11 1995-12-13 Wellcome Found Therapeutically active compounds
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
DK0780386T3 (da) 1995-12-20 2003-02-03 Hoffmann La Roche Matrixmetalloproteaseinhibitorer
GB9603095D0 (en) 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
NZ331191A (en) 1996-03-05 2000-03-27 Zeneca Ltd 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof
HRP970371A2 (en) 1996-07-13 1998-08-31 Kathryn Jane Smith Heterocyclic compounds
US6391874B1 (en) 1996-07-13 2002-05-21 Smithkline Beecham Corporation Fused heterocyclic compounds as protein tyrosine kinase inhibitors
AR007855A1 (es) 1996-07-13 1999-11-24 Glaxo Group Ltd Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios, uso en medicinay composiciones farmaceuticas que los contienen
EP0923585B1 (en) 1996-07-18 2002-05-08 Pfizer Inc. Phosphinate based inhibitors of matrix metalloproteases
EP0922030A1 (en) 1996-08-23 1999-06-16 Pfizer Inc. Arylsulfonylamino hydroxamic acid derivatives
US6077864A (en) 1997-01-06 2000-06-20 Pfizer Inc. Cyclic sulfone derivatives
HUP0000852A2 (hu) 1997-02-03 2001-05-28 Pfizer Products Inc. Aril-szulfonil-amino-hidroxámsav-származékok, valamint e vegyületeket tartalmazó gyógyászati készítmények
JP2000507975A (ja) 1997-02-07 2000-06-27 ファイザー・インク N−ヒドロキシ−β−スルホニルプロピオンアミド誘導体類及びそれらのマトリックスメタロプロテイナーゼ阻害薬としての使用
NZ336836A (en) 1997-02-11 2001-02-23 Pfizer Arylsulfonyl hydroxamic acid derivatives suitable for a broad range of medicinal treatments
CA2289102A1 (en) 1997-05-07 1998-11-12 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
CA2291709A1 (en) 1997-05-30 1998-12-03 Merck & Co., Inc. Novel angiogenesis inhibitors
DE69838172T2 (de) 1997-08-22 2008-04-10 Astrazeneca Ab Oxindolylchinazolinderivate als angiogenesehemmer
AU744939B2 (en) 1997-09-26 2002-03-07 Merck & Co., Inc. Novel angiogenesis inhibitors
SK6652000A3 (en) 1997-11-11 2002-05-09 Pfizer Prod Inc Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
GB9725782D0 (en) 1997-12-05 1998-02-04 Pfizer Ltd Therapeutic agents
RS49779B (sr) 1998-01-12 2008-06-05 Glaxo Group Limited, Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
GB9800575D0 (en) 1998-01-12 1998-03-11 Glaxo Group Ltd Heterocyclic compounds
GB9801690D0 (en) 1998-01-27 1998-03-25 Pfizer Ltd Therapeutic agents
PA8469501A1 (es) 1998-04-10 2000-09-29 Pfizer Prod Inc Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
PA8469401A1 (es) 1998-04-10 2000-05-24 Pfizer Prod Inc Derivados biciclicos del acido hidroxamico
KR100743287B1 (ko) 1998-05-29 2007-07-26 수젠, 인크. 피롤기로 치환된 2-인돌리논 단백질 인산화 효소 억제제
JP3270834B2 (ja) 1999-01-27 2002-04-02 ファイザー・プロダクツ・インク 抗がん剤として有用なヘテロ芳香族二環式誘導体
UA71945C2 (en) 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
CN1437594A (zh) 2000-06-22 2003-08-20 辉瑞产品公司 用于治疗异常细胞生长的取代的双环衍生物
US6451828B1 (en) 2000-08-10 2002-09-17 Elan Pharmaceuticals, Inc. Selective inhibition of glutaminase by bis-thiadiazoles
AR042586A1 (es) 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
DE10109807A1 (de) 2001-03-01 2002-09-05 Wella Ag Verbrückte Diaminopyrazole und diese Verbindungen enthaltende Färbemittel
US7029729B2 (en) 2003-02-24 2006-04-18 3M Innovative Properties Company Cholesteric liquid crystal additives
US7452893B2 (en) 2003-08-15 2008-11-18 Merck & Co., Inc. 4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists
EP1791835A2 (en) 2004-09-09 2007-06-06 Astellas Pharma Inc. Thiazole derivatives having vap-1 inhibitory activity
US8338437B2 (en) 2007-02-28 2012-12-25 Methylgene Inc. Amines as small molecule inhibitors
US20120077814A1 (en) 2010-09-10 2012-03-29 Zhong Wang Sulfonamide, sulfamate, and sulfamothioate derivatives
US8604016B2 (en) 2011-11-21 2013-12-10 Calithera Biosciences Inc. Heterocyclic inhibitors of glutaminase
CN108785305B (zh) * 2011-11-21 2021-10-29 卡利泰拉生物科技公司 谷氨酰胺酶的杂环抑制剂
US10181126B2 (en) 2012-03-13 2019-01-15 American Express Travel Related Services Company, Inc. Systems and methods for tailoring marketing
EP2888253A4 (en) 2012-08-24 2016-01-06 Univ Texas HETEROCYCLIC HIF ACTIVITY MODULATORS FOR THE TREATMENT OF DISEASES
HUE056078T2 (hu) 2012-11-16 2022-01-28 Calithera Biosciences Inc Heterociklusos glutamináz inhibitorok
SG11201504022RA (en) 2012-11-21 2015-06-29 Agios Pharmaceuticals Inc Glutamase inhibitors and method of use
WO2014079011A1 (en) 2012-11-22 2014-05-30 Agios Pharmaceuticals, Inc. Heterocyclic compounds for inhibiting glutaminase and their methods of use
HK1220640A1 (zh) 2012-12-03 2017-05-12 Calithera Biosciences, Inc. 用谷氨醯胺酶的杂环抑制剂治疗癌症
US9868705B2 (en) * 2013-09-27 2018-01-16 The Board Of Trustees Of The University Of Illinois Tetra-aryl cyclobutane inhibitors of androgen receptor action for the treatment of hormone refractory cancer
WO2015061432A1 (en) 2013-10-25 2015-04-30 Calithera Biosciences, Inc. Treatment of viral infections with inhibitors of glutaminase
KR20160100407A (ko) 2014-01-06 2016-08-23 리젠 파마슈티컬스 소시에떼 아노님 신규한 글루타미나제의 저해제
WO2015138902A1 (en) 2014-03-14 2015-09-17 Calithera Biosciences, Inc. Combination therapy with glutaminase inhibitors
EA201691896A1 (ru) 2014-03-21 2017-01-30 Аджиос Фармасьютикалз, Инк. Соединения и способы их применения
HRP20192056T1 (hr) * 2014-04-30 2020-02-21 Pfizer Inc. Derivati diheterocikla vezani na cikloalkil
SG11201610333VA (en) 2014-06-13 2017-01-27 Calithera Biosciences Inc Combination therapy with glutaminase inhibitors
WO2016014890A1 (en) 2014-07-24 2016-01-28 Calithera Biosciences, Inc. Treatment of multiple myeloma with heterocyclic inhibitors of glutaminase
JP6768693B2 (ja) 2015-03-30 2020-10-14 キャリセラ バイオサイエンシーズ, インコーポレイテッド グルタミナーゼ阻害剤を投与する方法
BR112017021312A2 (pt) 2015-04-06 2018-06-26 Calithera Biosciences Inc tratamento de câncer de pulmão com inibidores de glutaminase
US10884952B2 (en) 2016-09-30 2021-01-05 Intel Corporation Enforcing memory operand types using protection keys
JP6943759B2 (ja) 2017-12-28 2021-10-06 株式会社東海理化電機製作所 シフト装置

Similar Documents

Publication Publication Date Title
CY1118572T1 (el) Παραγωγο κυκλοαλκανιου
CY1123627T1 (el) Παραγωγα διυδροϊμιδαζοπυραζινονης χρησιμα στη θεραπευτικη αντιμετωπιση του καρκινου
JP2016540742A5 (cg-RX-API-DMAC10.html)
CY1120104T1 (el) Αναστολεις της syk
JP2016503799A5 (cg-RX-API-DMAC10.html)
JP2016537382A5 (cg-RX-API-DMAC10.html)
JP2016515561A5 (cg-RX-API-DMAC10.html)
EA201390401A1 (ru) ПИРАЗИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ENaC БЛОКАТОРОВ
JP2016515560A5 (cg-RX-API-DMAC10.html)
CY1117105T1 (el) Ενωσεις πυριδαζινονης και χρηση τους ως αναστολεις του daao
JP2016518328A5 (cg-RX-API-DMAC10.html)
MX2020002924A (es) Lactamas fusionadas de arilo y heteroarilo.
EA201591457A8 (ru) Терапевтические соединения
EA201591301A1 (ru) Новые пиримидиновые и пиридиновые соединения и их применение
WO2014152389A8 (en) Imaging agent for detection of diseased cells
NZ631738A (en) (hetero) arylacetamide derivatives as antiretroviral agents
MX373935B (es) Compuestos antiproliferativos y métodos de uso de los mismos.
TN2016000090A1 (en) Substituted quinolizine derivatives useful as hiv integrase inhibitors.
JP2016530259A5 (cg-RX-API-DMAC10.html)
NZ703064A (en) Inhibitors of hepatitis c virus
MD20160012A2 (ro) Formulare de inhibitori SYK
JP2017523152A5 (cg-RX-API-DMAC10.html)
JP2014526533A5 (cg-RX-API-DMAC10.html)
RU2018105614A (ru) Производное 1,3,5-триазина и способ его применения
JP2016531126A5 (cg-RX-API-DMAC10.html)